Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Revenue: 2020-2024

Historic Revenue for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $37.3 million.

  • Biofrontera's Revenue fell 22.46% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 5.11%. This contributed to the annual value of $37.3 million for FY2024, which is 9.54% up from last year.
  • Per Biofrontera's latest filing, its Revenue stood at $37.3 million for FY2024, which was up 9.54% from $34.1 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Revenue registered a high of $50.0 million during FY2020, and its lowest value of $24.1 million during FY2021.
  • In the last 3 years, Biofrontera's Revenue had a median value of $34.1 million in 2023 and averaged $33.4 million.
  • As far as peak fluctuations go, Biofrontera's Revenue plummeted by 51.80% in 2021, and later rose by 18.98% in 2022.
  • Biofrontera's Revenue (Yearly) stood at $50.0 million in 2020, then crashed by 51.80% to $24.1 million in 2021, then increased by 18.98% to $28.7 million in 2022, then grew by 18.82% to $34.1 million in 2023, then increased by 9.54% to $37.3 million in 2024.